1,439 results on '"Scorilas, Andreas"'
Search Results
202. The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer
203. The role of transcription factors in laboratory medicine
204. Quantified KLK15 Gene Expression Levels Discriminate Prostate Cancer From Benign Tumors and Constitute a Novel Independent Predictor of Disease Progression
205. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma
206. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers
207. A comprehensive nanopore sequencing methodology deciphers the complete transcriptional landscape of cyclin‐dependent kinase 4 (CDK4) in human malignancies.
208. Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter
209. L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer
210. Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer
211. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance
212. Kallikrein-Related Peptidases (KLKs) as Novel Potential Biomarkers In Gastric Cancer: An Open Yet Challenging Road Lies Ahead
213. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors
214. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: Quantitative expression analysis and evaluation of its clinical significance
215. Contribution of miRNAs, tRNAs and tRFs to Aberrant Signaling and Translation Deregulation in Lung Cancer
216. Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report
217. The interplay between miR-1245a and BRCA2 in colorectal cancer
218. Circular RNAs: A New Piece in the Colorectal Cancer Puzzle
219. Complex transcriptional regulation of the BCL2L12 gene: Novel, active promoter in K562 cells
220. miR ‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients
221. Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3′RACE and high-throughput sequencing
222. KLK12 (kallikrein-related peptidase 12)
223. JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer
224. KLK6 (kallikrein-related peptidase 6)
225. Identification of novel alternative transcripts of the human Ribonuclease κ (RNASEK) gene using 3′ RACE and high-throughput sequencing approaches
226. The miR-200 family as prognostic markers in clear cell renal cell carcinoma
227. Natural Alkaloids Intervening the Insulin Pathway: New Hopes for Anti-Diabetic Agents?
228. A Molecular Signature of Three tRNA-Derived RNA Fragments May Discriminate Smoldering from Symptomatic Multiple Myeloma Patients
229. The Clinical Significance of a Novel microRNA Signature in Multiple Myeloma
230. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy
231. Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma
232. BOK (BCL2 family apoptosis regulator BOK)
233. Identification of novel alternative splice variants of the human L-DOPA decarboxylase (DDC) gene in human cancer cells, using high-throughput sequencing approaches
234. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies
235. KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone
236. Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia
237. Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility
238. Molecular Response of HL-60 Cells to Mitotic Inhibitors Vincristine and Taxol Visualized with Apoptosis-Related Gene Expressions, Including the New Member BCL2L12
239. Human Tissue Kallikreins: From Gene Structure to Function and Clinical Applications
240. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer
241. Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)
242. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol
243. Total and Free PSA Kinetics in Patients Without Prostate Cancer Undergoing Radical Cystoprostatectomy
244. A Molecular Signature of Three tRNA-Derived RNA Fragments May Discriminate Smoldering from Symptomatic Multiple Myeloma Patients
245. Molecular characterization, genomic structure and expression analysis of a gene (CATL1/CPT1C) encoding a third member of the human carnitine acyltransferase family
246. Translating transcriptome to immunophenotype in head and neck squamous cell carcinoma (HNSCC) to identify pathways promoting T-cell infiltration
247. The Clinical Significance of a Novel microRNA Signature in Multiple Myeloma
248. Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells
249. Breast Cancer Cells Response to the Antineoplastic Agents Cisplatin, Carboplatin, and Doxorubicin at the mRNA Expression Levels of Distinct Apoptosis-Related Genes, Including the New Member, BCL2L12
250. The role of human tissue kallikreins 7 and 8 in intracranial malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.